NCT00248287 2025-01-29CA225200US Oncology ResearchPhase 2 Active not recruiting154 enrolled 12 charts
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled